Department of Pathology, University of Alabama, Birmingham, USA.
Laboratory of Immunopharmacology and Experimental Therapeutics, Division of Cancer Research, Regional Cancer Centre, Medical College Campus, University of Kerala, Thiruvananthapuram, Kerala, 695011, India.
Curr Cancer Drug Targets. 2023;23(8):585-602. doi: 10.2174/1568009623666230320121332.
The dynamic mucosal layer provides a selective protective barrier for the epithelial cells lining the body cavities. Diverse human malignancies exploit their intrinsic role to protect and repair epithelia for promoting growth and survival. Aberrant expression of mucin has been known to be associated with poor prognosis of many cancers. However, the emergence of new paradigms in the study of metastasis recognizes the involvement of MUC1, MUC4, MUC5AC, MUC5B, and MUC16 during metastasis initiation and progression. Hence mucins can be used as an attractive target in future diagnostic and therapeutic strategies. In this review, we discuss in detail about mucin family and its domains and the role of different mucins in regulating cancer progression and metastasis. In addition, we briefly discuss insights into mucins as a therapeutic agent.
动态黏膜层为体腔衬里上皮细胞提供了选择性的保护屏障。多种人类恶性肿瘤利用其内在的保护和修复上皮的作用来促进生长和存活。已知黏蛋白的异常表达与许多癌症的预后不良有关。然而,在转移研究的新范例中,人们认识到 MUC1、MUC4、MUC5AC、MUC5B 和 MUC16 在转移起始和进展中的参与。因此,黏蛋白可以作为未来诊断和治疗策略中的一个有吸引力的靶点。在这篇综述中,我们详细讨论了黏蛋白家族及其结构域,以及不同黏蛋白在调节癌症进展和转移中的作用。此外,我们还简要讨论了将黏蛋白作为治疗剂的一些见解。